SLC5A2 and diabetic ketoacidosis: Fralick Fralick M M Schneeweiss Schneeweiss S S Patorno Patorno E E Risk of diabetic ketoacidosis after initiation of an SGLT2 inhibitor Risk of diabetic ketoacidosis after initiation of an SGLT2 inhibitor N Engl J Med N Engl J Med 2017 2017 376 376 23 23 2300 2300 2302 2302 10.1056/NEJMc1701990 10.1056/NEJMc1701990 28591538 28591538